Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells. (Q40628338)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Iain R Hutcheson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Janice M Knowlden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Tracie-Ann Madden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Denise Barrow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Alan E Wakeling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Robert I Nicholson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

81-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14531500%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of tamoxifen resistance

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R ty

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Oestrogen receptor: a stable phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Estrogen receptor pathways to AP-1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Functional synergy between the transcription factor Sp1 and the estrogen receptor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Regulation by Estrogen through the 5′-Flanking Region of the Transforming Growth Factor α Gene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Transforming growth factor alpha.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021

Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1025484908380

7 January 2021